Tag: juvenile myelomonocytic leukemia

Home / juvenile myelomonocytic leukemia

Categories

Azacitidine is approved by FDA for newly diagnosed juvenile myelomonocytic leukemia

June 2022: The FDA has approved the drug azacitidine (Vidaza, Celgene Corp.) for children with newly diagnosed juvenile myelomonocytic leukaemia (JMML).The pharmacokinetics, pharmacodynamics, safety,...
juvenile-myelomonocytic-leukemia

Scan the code